Treace Medical Concepts Set to Shine at Healthcare Conference
PONTE VEDRA, Fla. — Treace Medical Concepts, Inc. (NasdaqGS: TMCI) is gearing up for an exciting presentation at the upcoming 43rd Annual J.P. Morgan Healthcare Conference. This annual event is a prominent gathering for healthcare industry leaders, investors, and innovators.
Presentation Details
The Chief Executive Officer, John T. Treace, will take the stage on January 14, 2025, to share insights into the company's advancements and strategic direction. The presentation is scheduled to commence around 9:00 am PT and will showcase Treace’s commitment to enhancing surgical treatments for bunions and related midfoot deformities.
Accessing the Presentation
For those interested in following the presentation, a live webcast will be available on the Treace investor relations website. After the event, a replay will also be accessible, ensuring that stakeholders have the opportunity to catch up on the critical discussions and innovations presented during this influential conference.
Treace Medical Concepts: Pioneering Solutions
Treace Medical Concepts stands at the forefront of medical technology with its innovative solutions for bunion treatment. The company’s flagship products, the Lapiplasty® and Adductoplasty® procedures, have revolutionized the surgical management of bunions. Bunions, affecting nearly 67 million Americans, often necessitate surgical intervention for relief and correction. Treace estimates there are approximately 1.1 million annual surgical candidates requiring such treatments.
A Comprehensive Approach to Bunion Surgery
The foundation of Treace's approach lies in its patented Lapiplasty® 3D Bunion Correction® system. This unique method allows surgeons to address bunions across three dimensions, correcting the underlying instability of the joints effectively. This method not only alleviates pain but plays a vital role in restoring the active lifestyles of patients.
Advanced Solutions for Patients
Alongside its signature services, Treace has developed the Adductoplasty® Midfoot Correction System, aimed at enhancing surgical outcomes for patients suffering from midfoot deformities. Moreover, the new SpeedPlate™ Rapid Compression Implants have been introduced, providing an innovative fixation platform that exhibits versatility across various surgical procedures.
Commitment to Innovation and Community
Treace Medical Concepts remains committed to maintaining an open channel of communication with its investors and the public. The company routinely posts vital information relevant to its operations and business strategies within the “Investor Relations” section of its website. This dedication to transparency ensures that both current and potential investors are informed about advancements and initiatives underway at Treace.
Join Treace on Social Media
In addition to its robust website resources, Treace encourages engagement through various social media platforms, including LinkedIn, X, Facebook, and Instagram. By connecting with Treace, individuals can stay updated on the company's latest innovations, news, and community involvement.
Contact Information
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
mhair@treace.net
(904) 373-5940
Investors:
Gilmartin Group
Vivian Cervantes
IR@treace.net
Frequently Asked Questions
What is Treace Medical Concepts known for?
Treace Medical Concepts specializes in innovative surgical treatments for bunions and other midfoot deformities.
Who will present at the J.P. Morgan Healthcare Conference?
John T. Treace, the Chief Executive Officer, will be presenting at the conference.
What products does Treace offer?
Treace offers the Lapiplasty® 3D Bunion Correction® system and Adductoplasty® Midfoot Correction System, among others.
How can investors stay informed about Treace?
Investors can visit the Treace investor relations website and follow the company on social media for updates.
Why are bunion surgeries crucial?
Bunion surgeries are essential to alleviate pain and restore mobility to individuals affected by bunions, improving their quality of life.
